Search Results 1421-1430 of 17105 for Birth Control Evolution

1. Publications - Ellen D. Willis, M.D. - Mayo Clinic

   Tatini U, Willis ED, Novicki DE, Collins SA, Keate RF. Academic Excellence Day: A collaboration between Mayo Clinic Scottsdale and Maricopa Integrated Health ...

2. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   They must agree to use effective contraception throughout the study period. Subjects must be able to provide informed consent and understand, agree with ...

3. Improved Training Program for Fall Prevention of War Fighters with Lower Extremity Trauma - Mayo Clinic

   Third, we will identify, evaluate, and implement existing low cost technologies for measuring trunk control, the training outcome of critical importance ...

4. A Study of the Use of Molecular Breast Imaging to Evaluate Breast Cancer Tumor Response to Therapy that is Newly Supplemental to Standard Treatment - Mayo Clinic

   The purpose of this study is to evaluate the use of molecular breast imaging as an accurate way to assess the response of breast cancer tumors to chemotherapy ...

5. A Study to Assess DNA Tumor Markers in Whole Blood Specimens of Patients with Newly Diagnosed Lung Cancer - Mayo Clinic

   ... controls for each case group). For exploratory Disease Control group (Aim 4), 4 ml (minimum of 2 ml) plasma will be requested for each of following tumor ...

6. Movement disorders - Doctors and departments - Mayo Clinic

   Wei, M.D.. Physiatrist. Phoenix, AZ. Areas of focus: Botox injection, Neurogenic bladder and bowel management, Joint injection, Neurological rehabilitation, ...

7. Human Osteocalcin Gene Variant Functional Significance - Mayo Clinic

   Individuals carrying the OSTEOCALCIN SNP gene and age, sex, and race matched controls. Exclusion Criteria: Participants with a known diagnosis of type 1 or ...

8. An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738) - Mayo Clinic

   Controlled co-morbid conditions are not exclusionary if stable within three months of the Screening Visit; History or current evidence of long QT syndrome ...

9. A Study of the Safety and Effectiveness of Using Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia - Mayo Clinic

   ... contraception throughout the study; Adequately informed of the nature and risks of the study with written informed consent. Exclusion Criteria. Pregnant or ...

10. Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten - Mayo Clinic

    Controls: Healthy children empaneled in Mayo Clinic primary care (Family Medicine or Community Pediatrics) matched for age (±3 mo), sex, and BMI (±0.5 kg/m^2).